Ingredients

The Medicine Maker's William Aryitey speaks with Dago Caceres from Dow Pharmaceuticals.

The Medicine Maker's James Strachan speaks with Francois Scheffler from BASF.

How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.

Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.

The industry requires reassurance on elemental impurities. How can media suppliers provide confidence in this area?

Unravelling the challenges and trends in formulation best practice – and why softgels and lipids are leading the way

Nine years ago we set out to characterize and evaluate our raw materials - this is what we found out…

Today's small molecules are increasingly complex, but generic producers must keep track of trends

Sitting Down With… Abhijit Mukherjee, COO of Dr. Reddy's Laboratories, India

One of the biggest pharma trade shows in Europe kicks off at the end of October